Patents Assigned to HyperBranch Medical Technology, Inc.
  • Patent number: 11826485
    Abstract: One aspect of the present invention generally relates to methods of sealing a wound or tissue plane or filling a void splace. In a preferred embodiment, the wound is an ophthalmic, pleural or dural wound. In certain instances, the compositions used to seal the wound or tissue plane comprises a polyalkyleneimine. In a preferred embodiment, the polyalkyleneimine is polyethyleneimine. Treatment of the polyethyleneimine with a cross-linking reagent causes the polyethyleneimine polymers to polymerize forming a seal. In certain instances, the cross-linking reagent is a polyethylene glycol having reactive terminal groups. In certain instances, the reactive terminal groups are activated esters, such as N-hydroxy succinimide ester. In certain instances, the reactive terminal groups are isocyanates. In certain instances, the polyethyleneimine has a lysine, cysteine, isocysteine or other nucleophilic group attached to the periphery of the polymer.
    Type: Grant
    Filed: April 23, 2021
    Date of Patent: November 28, 2023
    Assignee: HyperBranch Medical Technology, Inc.
    Inventors: Kenneth E. Stockman, Michael A. Carnahan, Keith R. D'Alessio, Mark W. Grinstaff
  • Patent number: 11027043
    Abstract: One aspect of the present invention generally relates to methods of sealing a wound or tissue plane or filling a void splace. In a preferred embodiment, the wound is an ophthalmic, pleural or dural wound. In certain instances, the compositions used to seal the wound or tissue plane comprises a polyalkyleneimine. In a preferred embodiment, the polyalkyleneimine is polyethyleneimine. Treatment of the polyethyleneimine with a cross-linking reagent causes the polyethyleneimine polymers to polymerize forming a seal. In certain instances, the cross-linking reagent is a polyethylene glycol having reactive terminal groups. In certain instances, the reactive terminal groups are activated esters, such as N-hydroxy succinimide ester. In certain instances, the reactive terminal groups are isocyanates. In certain instances, the polyethyleneimine has a lysine, cysteine, isocysteine or other nucleophilic group attached to the periphery of the polymer.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: June 8, 2021
    Assignee: HyperBranch Medical Technology, Inc.
    Inventors: Kenneth E. Stockman, Michael A. Carnahan, Keith R. D'Alessio, Mark W. Grinstaff
  • Patent number: 10952709
    Abstract: Provided is an extended length, flexible or bendable spray tip assembly for use with a multi-component surgical sealant. The tip assembly is particularly suited for use in surgical procedures having limited access to a surgical field, for example, neurosurgical procedures involving infratentorial, skull base, or transsphenoidal craniotomy, as well as the spine. The tip assembly can be used in combination with a multi-component delivery system or applicator.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: March 23, 2021
    Assignee: HyperBranch Medical Technology, Inc.
    Inventor: Keith R. D'Alessio
  • Patent number: 10688216
    Abstract: One aspect of the present invention generally relates to methods of sealing a wound or tissue plane or filling a void splace. In a preferred embodiment, the wound is an ophthalmic, pleural or dural wound. In certain instances, the compositions used to seal the wound or tissue plane comprises a polyalkyleneimine. In a preferred embodiment, the polyalkyleneimine is polyethyleneimine. Treatment of the polyethyleneimine with a cross-linking reagent causes the polyethyleneimine polymers to polymerize forming a seal. In certain instances, the cross-linking reagent is a polyethylene glycol having reactive terminal groups. In certain instances, the reactive terminal groups are activated esters, such as N-hydroxy succinimide ester. In certain instances, the reactive terminal groups are isocyanates. In certain instances, the polyethyleneimine has a lysine, cysteine, isocysteine or other nucleophilic group attached to the periphery of the polymer.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: June 23, 2020
    Assignee: HyperBranch Medical Technology, Inc.
    Inventors: Kenneth E. Stockman, Michael A. Carnahan, Keith R. D'Alessio, Mark W. Grinstaff
  • Patent number: 9878066
    Abstract: One aspect of the present invention generally relates to methods of sealing a wound or tissue plane or filling a void splace. In a preferred embodiment, the wound is an ophthalmic, pleural or dural wound. In certain instances, the compositions used to seal the wound or tissue plane comprises a polyalkyleneimine. In a preferred embodiment, the polyalkyleneimine is polyethyleneimine. Treatment of the polyethyleneimine with a cross-linking reagent causes the polyethyleneimine polymers to polymerize forming a seal. In certain instances, the cross-linking reagent is a polyethylene glycol having reactive terminal groups. In certain instances, the reactive terminal groups are activated esters, such as N-hydroxy succinimide ester. In certain instances, the reactive terminal groups are isocyanates. In certain instances, the polyethyleneimine has a lysine, cysteine, isocysteine or other nucleophilic group attached to the periphery of the polymer.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: January 30, 2018
    Assignee: HYPERBRANCH MEDICAL TECHNOLOGY, INC.
    Inventors: Kenneth E. Stockman, Michael A. Carnahan, Keith R. D'Alessio, Mark W. Grinstaff
  • Patent number: 9393344
    Abstract: One aspect of the present invention generally relates to methods of sealing a wound or tissue plane or filling a void splace. In a preferred embodiment, the wound is an ophthalmic, pleural or dural wound. In certain instances, the compositions used to seal the wound or tissue plane comprises a polyalkyleneimine. In a preferred embodiment, the polyalkyleneimine is polyethyleneimine. Treatment of the polyethyleneimine with a cross-linking reagent causes the polyethyleneimine polymers to polymerize forming a seal. In certain instances, the cross-linking reagent is a polyethylene glycol having reactive terminal groups. In certain instances, the reactive terminal groups are activated esters, such as N-hydroxy succinimide ester. In certain instances, the reactive terminal groups are isocyanates. In certain instances, the polyethyleneimine has a lysine, cysteine, isocysteine or other nucleophilic group attached to the periphery of the polymer.
    Type: Grant
    Filed: January 11, 2007
    Date of Patent: July 19, 2016
    Assignee: HyperBranch Medical Technology, Inc.
    Inventors: Kenneth E. Stockman, Michael A. Carnahan, Keith R. D'Alessio, Mark W. Grinstaff
  • Patent number: 8846022
    Abstract: One aspect of the present invention relates to methods of sealing a wound or tissue plane or filling a void space, or securing meshes, films or other devices within the body. In certain embodiments, the wound is an ophthalmic, pleural or dural wound, or a hernia repair mesh. Remarkably, disclosed herein is the discovery that the use of certain crosslinkers in combination with polyalkyleneimines at specific concentrations can result in hydrogels with tunable degradation properties.
    Type: Grant
    Filed: October 21, 2010
    Date of Patent: September 30, 2014
    Assignee: HyperBranch Medical Technology, Inc.
    Inventors: Michael A. Carnahan, Jared Daniel Goodnow Butlin
  • Publication number: 20130338631
    Abstract: Aspects of the invention relate to an applicator which can house multiple components of a formulation in separate receptacles. In certain embodiments, an applicator of the invention can be used for, but is not limited to, applying hydrogel formulations to dura mater, abdominal tissue in hernia repair, tissues near the spine, lung tissue, intestinal tissue, or any of the internal tissues.
    Type: Application
    Filed: March 14, 2011
    Publication date: December 19, 2013
    Applicant: HyperBranch Medical Technology, Inc.
    Inventors: Jared D. G. Butlin, Keith R. D'Alessio
  • Patent number: 8410189
    Abstract: One aspect of the present invention relates to methods of sealing a wound or tissue plane or filling a void space, or securing meshes, films or other devices within the body. In certain embodiments, the wound is an ophthalmic, pleural or dural wound, or a hernia repair mesh. Remarkably, disclosed herein is the discovery that the use of certain crosslinkers in combination with polyalkyleneimines at specific concentrations can result in hydrogels with tunable degradation properties.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: April 2, 2013
    Assignee: HyperBranch Medical Technology, Inc.
    Inventors: Michael A. Carnahan, Jared D. G. Butlin
  • Patent number: 8343183
    Abstract: Aspects of the invention relate to an applicator, and methods of use thereof, which can house multiple component formulations in separate material receptacles, which components can then be easily combined at the time of use without assembly by the user. In certain embodiments, a device of the invention can be used for, but is not limited to, applying hydrogel formulations to dura mater, abdominal tissue in hernia repair, tissues near the spine, lung tissue, intestinal tissue, or any of the internal tissues. In certain embodiments, a device of the invention can be configured to apply a spray or a stream of a liquid formulation to a surface. In certain embodiments, a device of the invention can be configured to deliver the formulation through an endoscope or laparoscope.
    Type: Grant
    Filed: April 30, 2010
    Date of Patent: January 1, 2013
    Assignee: HyperBranch Medical Technology, Inc.
    Inventors: Keith R. D'Alessio, Matthew Justin Morton, John L. Manhard, Stephen William Cline, Jared Daniel Goodnow Butlin, John Conn
  • Patent number: 8323262
    Abstract: Certain aspects of the invention relate to an applicator, and methods of use thereof, which can house multiple component formulations in separate material receptacles, which can then be easily reconstituted at time of use without any assembly by the user. A device of the invention can be used for, but is not limited to, applying hydrogel formulations to dura mater, abdominal tissue in hernia repair, tissues near the spine, lung tissue, intestinal tissue, and any of the internal tissues. A device of the invention can be configured to apply a spray or a stream of liquid formulation onto a surface to be treated. A device of the invention can be configured to deliver the formulation through an endoscope or laparoscope.
    Type: Grant
    Filed: July 8, 2009
    Date of Patent: December 4, 2012
    Assignee: HyperBranch Medical Technology, Inc.
    Inventors: Keith R. D'Alessio, Jeffrey G. Clark, Roy R. B. Attride, Wai N. Chin, Robert M. Colonna, Tomas Matusaitis, Todd J. Taylor, Christopher R. Yahnker
  • Patent number: 8262608
    Abstract: One aspect of the invention relates to an applicator system, and methods of use thereof, that can be used to house separately one or more liquids and one or more solids (e.g., components of a polymerizable hydrogel). In certain embodiments, the applicator systems are further designed to facilitate the mixing of the solids and liquids inside the applicator. In addition, in certain embodiments, the applicator systems are also designed to facilitate the application of the mixture to a surface.
    Type: Grant
    Filed: January 25, 2008
    Date of Patent: September 11, 2012
    Assignee: HyperBranch Medical Technology, Inc.
    Inventors: Jeffrey G. Clark, Keith R. D'Alessio
  • Publication number: 20110044932
    Abstract: One aspect of the present invention relates to methods of sealing a wound or tissue plane or filling a void space, or securing meshes, films or other devices within the body. In certain embodiments, the wound is an ophthalmic, pleural or dural wound, or a hernia repair mesh. Remarkably, disclosed herein is the discovery that the use of certain crosslinkers in combination with polyalkyleneimines at specific concentrations can result in hydrogels with tunable degradation properties.
    Type: Application
    Filed: October 21, 2010
    Publication date: February 24, 2011
    Applicant: HyperBranch Medical Technology, Inc.
    Inventors: Michael A. Carnahan, Jared D.G. Butlin
  • Publication number: 20100280312
    Abstract: Aspects of the invention relate to an applicator, and methods of use thereof, which can house multiple component formulations in separate material receptacles, which components can then be easily combined at the time of use without assembly by the user. In certain embodiments, a device of the invention can be used for, but is not limited to, applying hydrogel formulations to dura mater, abdominal tissue in hernia repair, tissues near the spine, lung tissue, intestinal tissue, or any of the internal tissues. In certain embodiments, a device of the invention can be configured to apply a spray or a stream of a liquid formulation to a surface. In certain embodiments, a device of the invention can be configured to deliver the formulation through an endoscope or laparoscope.
    Type: Application
    Filed: April 30, 2010
    Publication date: November 4, 2010
    Applicant: HyperBranch Medical Technology, Inc.
    Inventors: Keith R. D'Alessio, Matthew J. Morton, John L. Manhard, Stephen W. Cline, Jared D.G Butlin, John Conn
  • Publication number: 20100280547
    Abstract: One aspect of the invention relates to a simple, inexpensive applicator system which can be used for the delivery of a hydrogel formulation. In certain embodiments, the applicator system is suitable for use in sealing of dura mater, especially dura matter within the spinal column. In other embodiments, the applicator system may be used to repair cardiovascular defects, defects of the gall or urinary bladder, or repair of any of the other ducts within the body.
    Type: Application
    Filed: April 30, 2010
    Publication date: November 4, 2010
    Applicant: HyperBranch Medical Technology, Inc.
    Inventors: Keith R. D'Alessio, Michael A. Carnahan, Jared D. G. Butlin
  • Publication number: 20100069927
    Abstract: One aspect of the present invention generally relates to methods of sealing a defect, wound or void using a two component system composed of masking material, which creates an anti-adhesion barrier, and a covering material. In certain embodiment, the covering material comprises an in situ polymerizing sealant. In certain embodiments, the in situ polymerizing sealant is a hydrogel which binds to the healthy tissue but remain unadhered to the area under the masking material. In certain embodiments, the masking material is also a hydrogel. In certain embodiments, normal biological processes may dissolve away the masking material leaving a protective cover of polymerized sealant over the wound site.
    Type: Application
    Filed: July 22, 2008
    Publication date: March 18, 2010
    Applicant: HyperBranch Medical Technology, Inc.
    Inventors: Jeffrey G. Clark, Robert Naslund, Kenneth E. Stockman
  • Publication number: 20100010473
    Abstract: Certain aspects of the invention relate to an applicator, and methods of use thereof, which can house multiple component formulations in separate material receptacles, which can then be easily reconstituted at time of use without any assembly by the user. A device of the invention can be used for, but is not limited to, applying hydrogel formulations to dura mater, abdominal tissue in hernia repair, tissues near the spine, lung tissue, intestinal tissue, and any of the internal tissues. A device of the invention can be configured to apply a spray or a stream of liquid formulation onto a surface to be treated. A device of the invention can be configured to deliver the formulation through an endoscope or laparoscope.
    Type: Application
    Filed: July 8, 2009
    Publication date: January 14, 2010
    Applicant: HyperBranch Medical Technology, Inc.
    Inventors: Keith R. D'Alessio, Jeffrey G. Clark, Roy R.B. Attride, Wai N. Chin, Robert M. Colonna, Tomas Matusaitis, Todd J. Taylor, Christopher R. Yahnker
  • Publication number: 20090215923
    Abstract: One aspect of the present invention relates to methods of sealing a wound or tissue plane or filling a void space, or securing meshes, films or other devices within the body. In certain embodiments, the wound is an ophthalmic, pleural or dural wound, or a hernia repair mesh. Remarkably, disclosed herein is the discovery that the use of certain crosslinkers in combination with polyalkyleneimines at specific concentrations can result in hydrogels with tunable degradation properties.
    Type: Application
    Filed: February 13, 2009
    Publication date: August 27, 2009
    Applicant: HyperBranch Medical Technology, Inc.
    Inventors: Michael A. Carnahan, Jared D. G. Butlin
  • Publication number: 20080195040
    Abstract: One aspect of the invention relates to an applicator system, and methods of use thereof, that can be used to house separately one or more liquids and one or more solids (e.g., components of a polymerizable hydrogel). In certain embodiments, the applicator systems are further designed to facilitate the mixing of the solids and liquids inside the applicator. In addition, in certain embodiments, the applicator systems are also designed to facilitate the application of the mixture to a surface.
    Type: Application
    Filed: January 25, 2008
    Publication date: August 14, 2008
    Applicant: HyperBranch Medical Technology, Inc.
    Inventors: Jeffrey A. Clark, Keith R. D'Alessio
  • Publication number: 20070196454
    Abstract: One aspect of the present invention generally relates to methods of sealing a wound or tissue plane or filling a void splace. In a preferred embodiment, the wound is an ophthalmic, pleural or dural wound. In certain instances, the compositions used to seal the wound or tissue plane comprises a polyalkyleneamine. In a preferred embodiment, the polyalkyleneamine is polyethyleneimine. Treatment of the polyethyleneimine with a cross-linking reagent causes the polyethyleneimine polymers to polymerize forming a seal. In certain instances, the cross-linking reagent is a polyethylene glycol having reactive terminal groups. In certain instances, the reactive terminal groups are activated esters, such as N-hydroxy succinimide ester. In certain instances, the reactive terminal groups are isocyanates. In certain instances, the polyethyleneimine has a lysine, cysteine, isocysteine or other nucleophilic group attached to the periphery of the polymer.
    Type: Application
    Filed: January 11, 2007
    Publication date: August 23, 2007
    Applicant: Hyperbranch Medical Technology, Inc.
    Inventors: Kenneth Stockman, Michael Carnahan, Keith D'Alessio, Mark Grinstaff